Correlation Between Krebs Biochemicals and Nazara Technologies

Can any of the company-specific risk be diversified away by investing in both Krebs Biochemicals and Nazara Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krebs Biochemicals and Nazara Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Krebs Biochemicals and and Nazara Technologies Limited, you can compare the effects of market volatilities on Krebs Biochemicals and Nazara Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krebs Biochemicals with a short position of Nazara Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krebs Biochemicals and Nazara Technologies.

Diversification Opportunities for Krebs Biochemicals and Nazara Technologies

0.45

Correlation Coefficient

Krebs Biochemicals  Nazara Technologies

Very weak diversification

The 3 months correlation between Krebs and Nazara is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Krebs Biochemicals and and Nazara Technologies Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nazara Technologies and Krebs Biochemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krebs Biochemicals and are associated (or correlated) with Nazara Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nazara Technologies has no effect on the direction of Krebs Biochemicals i.e., Krebs Biochemicals and Nazara Technologies go up and down completely randomly.

Pair Corralation between Krebs Biochemicals and Nazara Technologies

Assuming the 90 days trading horizon Krebs Biochemicals and is expected to generate 1.78 times more return on investment than Nazara Technologies. However, Krebs Biochemicals is 1.78 times more volatile than Nazara Technologies Limited. It trades about 0.13 of its potential returns per unit of risk. Nazara Technologies Limited is currently generating about 0.08 per unit of risk. If you would invest  8,397  in Krebs Biochemicals and on August 31, 2024 and sell it today you would earn a total of  2,896  from holding Krebs Biochemicals and or generate 34.49% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Krebs Biochemicals and  vs.  Nazara Technologies Limited

Krebs Biochemicals and

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Nazara Technologies

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Nazara Technologies Limited are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nazara Technologies sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Krebs Biochemicals and Nazara Technologies

The main advantage of trading using opposite Krebs Biochemicals and Nazara Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krebs Biochemicals position performs unexpectedly, Nazara Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nazara Technologies will offset losses from the drop in Nazara Technologies' long position.

The idea behind Krebs Biochemicals and and Nazara Technologies Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.